₹ 1.1 Cr
Volume Transacted
(Jan 3, 2025)
6.8 K
Stocks Traded
(Jan 3, 2025)
Last Updated on: Jan 04, 2025
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
03 Jan 2025 | 1636.05 | 1647.35 | 1647.35 | 1617.35 |
02 Jan 2025 | 1638.95 | 1611.3 | 1641.85 | 1595 |
01 Jan 2025 | 1614.05 | 1630.95 | 1630.95 | 1602 |
31 Dec 2024 | 1608.85 | 1599.65 | 1620.95 | 1588.55 |
30 Dec 2024 | 1589.8 | 1586.1 | 1601.6 | 1576.9 |
27 Dec 2024 | 1585.4 | 1559.95 | 1604.9 | 1553.15 |
26 Dec 2024 | 1540.95 | 1516.05 | 1547.55 | 1511.15 |
24 Dec 2024 | 1536.15 | 1551.2 | 1562.05 | 1530 |
23 Dec 2024 | 1549.95 | 1552.25 | 1565.95 | 1534.8 |
20 Dec 2024 | 1542.35 | 1517.25 | 1560 | 1517.25 |
Date | Price (₹) |
---|---|
03 Jan 2025 | 1636.05 |
02 Jan 2025 | 1638.95 |
01 Jan 2025 | 1614.05 |
31 Dec 2024 | 1608.85 |
30 Dec 2024 | 1589.8 |
27 Dec 2024 | 1585.4 |
26 Dec 2024 | 1540.95 |
24 Dec 2024 | 1536.15 |
23 Dec 2024 | 1549.95 |
20 Dec 2024 | 1542.35 |
Glenmark Pharmaceuticals Inc. USA launches Lacosamide Oral Solution
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Lacosamide Oral Solu...
16 Dec 2024 09:06
Glenmark Pharma arm launches seizure drug in US
The newly launched drug is bioequivalent and therapeutically equivalent to the reference l...
16 Dec 2024 09:41
Glenmark Pharmaceuticals Ltd up for third straight session
Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...
03 Dec 2024 13:06
Glenmark Pharma launches Travoprost Ophthalmic Solution USP
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Travoprost Ophthalmi...
27 Nov 2024 09:12
Glenmark Pharma arm launches Travoprost Ophthalmic Solution in U.S market
Travoprost ophthalmic is used to treat glaucoma (a condition in which increased pressure i...
27 Nov 2024 09:59
Glenmark Pharmaceuticals Ltd eases for fifth straight session
Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...
18 Nov 2024 13:35
Unlimited trading starting at just Rs. 249*